BioPharma
Eli Lilly Becomes the First Drugmaker to Hit $1tn Valuation
Eli Lilly, the US pharma giant, has become the first drugmaker to hit $1tn valuation on November 22, 2025, hence entering the exclusive club, which...
BioPharma
FDA Looks to Accelerate Biosimilar Drug Development
The FDA has gone on to propose certain new policies in order to accelerate biosimilar drug development and at the same time also lower the...
BioPharma
Onshoring of Drug Product Manufacturing to Massachusetts
Moderna is set to expand its US manufacturing capabilities through the onshoring of drug product manufacturing to its present Moderna Technology Center - MTC located Norwood,...
BioPharma
Cyclical Saviors: Cyclodextrins and Patient-Centric Drug Design
Explore how cyclodextrins in advanced biopharma delivery enhance drug stability, bioavailability, patient access and new formats for innovative treatments.
BioPharma
Innovations in Clinical Packaging and Labeling for Global Studies
The sophistication of clinical trial management continues to advance at an unprecedented pace, and nowhere is this transformation more evident than in clinical packaging and...
BioPharma
Decentralized Clinical Trials: New Demands on Clinical Supply Strategies
The clinical research landscape is experiencing a significant paradigm shift toward decentralized and hybrid trial models that fundamentally alter how clinical supplies are managed, distributed,...
BioPharma
The Rise of Pharma 4.0: Digital Twins, AI and Predictive Manufacturing
The pharmaceutical manufacturing industry stands at a transformative inflection point. For decades, manufacturing processes operated based on established protocols perfected through empirical experience and regulatory...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.